BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15602032)

  • 41. Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trial.
    Fleischmann R; Kavanaugh A; Smolen J
    Rheumatology (Oxford); 2013 Mar; 52(3):409-10. PubMed ID: 23070312
    [No Abstract]   [Full Text] [Related]  

  • 42. When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?
    Smolen JS; Weinblatt ME
    Ann Rheum Dis; 2008 Nov; 67(11):1497-8. PubMed ID: 18854512
    [No Abstract]   [Full Text] [Related]  

  • 43. Should we use poor prognosis factors to start early treatment in patients with rheumatoid arthritis?
    Valor L; de la Torre Ortega I
    Reumatol Clin; 2012; 8(4):163-7. PubMed ID: 22317850
    [No Abstract]   [Full Text] [Related]  

  • 44. An update in the management of rheumatoid arthritis.
    Abid N
    J Pak Med Assoc; 2005 Apr; 55(4):167-9. PubMed ID: 15918631
    [No Abstract]   [Full Text] [Related]  

  • 45. Paying attention to the preciseness of conclusion.
    Yuan K; Chen J; Li T; Xu A
    Ann Rheum Dis; 2014 Nov; 73(11):e66. PubMed ID: 25038235
    [No Abstract]   [Full Text] [Related]  

  • 46. Rheumatoid arthritis in 2003: where are we now with treatment?
    Weinblatt ME
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii94-6. PubMed ID: 14532160
    [No Abstract]   [Full Text] [Related]  

  • 47. Editorial: treat to target in rheumatoid arthritis: good for the joints as well as the heart?
    Nurmohamed MT
    Arthritis Rheumatol; 2015 Jun; 67(6):1412-5. PubMed ID: 25779912
    [No Abstract]   [Full Text] [Related]  

  • 48. When to initiate and discontinue biologic treatments for rheumatoid arthritis?
    Chatzidionysiou K; van Vollenhoven RF
    J Intern Med; 2011 Jun; 269(6):614-25. PubMed ID: 21261760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacological management of rheumatoid arthritis: the state of the art and the future perspective].
    Kameda H; Takeuchi T
    Nihon Rinsho; 2013 Jul; 71(7):1166-71. PubMed ID: 23961662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The TRIFRA trial: efforts employed to minimise expectation bias.
    Lv QW; Zhang W; Shi Q; Zheng WJ; Lipsky PE; Zhang X
    Ann Rheum Dis; 2014 Nov; 73(11):e67. PubMed ID: 25057182
    [No Abstract]   [Full Text] [Related]  

  • 51. Methotrexate use in rheumatoid arthritis.
    O'Dell JR
    Rheum Dis Clin North Am; 1997 Nov; 23(4):779-96. PubMed ID: 9361155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of rheumatoid arthritis].
    Bolten WW
    MMW Fortschr Med; 2008 Aug; 150(32-35):50-3; quiz 54. PubMed ID: 19006884
    [No Abstract]   [Full Text] [Related]  

  • 53. Avoiding common pitfalls in the analysis of observational studies of new treatments for rheumatoid arthritis.
    Hudson M; Suissa S
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):805-10. PubMed ID: 20535791
    [No Abstract]   [Full Text] [Related]  

  • 54. Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease.
    Kavanaugh AF; Mayer LF; Cush JJ; Hanauer SB
    Am J Med; 2011 Apr; 124(4 Suppl):e1-18. PubMed ID: 21531240
    [No Abstract]   [Full Text] [Related]  

  • 55. Biologicals for rheumatoid arthritis.
    Tugwell P; Singh JA; Wells GA
    BMJ; 2011 Jul; 343():d4027. PubMed ID: 21798970
    [No Abstract]   [Full Text] [Related]  

  • 56. [Focusing on the use of biologics in rheumatoid arthritis].
    Devauchelle-Pensec V; Guellec D
    Rev Prat; 2015 May; 65(5):687-8. PubMed ID: 26165113
    [No Abstract]   [Full Text] [Related]  

  • 57. Bridging the gap between aggregate data and individual patient management: a Bayesian approach.
    van der Wilt GJ; Groenewoud H; van Riel P
    Int J Technol Assess Health Care; 2011 Apr; 27(2):133-8. PubMed ID: 21473812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Optimized treatment of a patient having rheumatoid arthritis and gout at the same time].
    Nordström D; Leirisalo-Repo M; Petterson T
    Duodecim; 2013; 129(10):1045-8. PubMed ID: 23767136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New therapeutic approaches. 2. New anti-rheumatic drugs: with special reference to methotrexate].
    Eguchi K
    Nihon Naika Gakkai Zasshi; 2000 Oct; 89(10):2138-45. PubMed ID: 11215129
    [No Abstract]   [Full Text] [Related]  

  • 60. Methotrexate for rheumatoid arthritis: a guide from Canada.
    Verstappen SM; Hyrich KL
    J Rheumatol; 2010 Jul; 37(7):1374-6. PubMed ID: 20595290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.